id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OAR-2009-0566-0032,EPA,EPA-HQ-OAR-2009-0566,Protection of Stratospheric Ozone:  Allocation of Essential Use Allowances for Calendar Year 2010,Rule,Federal Register Document,2010-05-10T04:00:00Z,2010,5,,,2011-06-11T16:05:50Z,2010-10926,0,0,0900006480aea2df
EPA-HQ-OAR-2009-0566-0006,EPA,EPA-HQ-OAR-2009-0566,US Nomination of Metered Dose Inhalers (MDIs) as an Essential Use for 2010,Supporting & Related Material,Application,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:24:38Z,,0,0,0900006480a56615
EPA-HQ-OAR-2009-0566-0008,EPA,EPA-HQ-OAR-2009-0566,Decision VIII/10,Supporting & Related Material,"Guidance, Interpretation, Policy, Procedure",2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:24:44Z,,0,0,0900006480a566ad
EPA-HQ-OAR-2009-0566-0018,EPA,EPA-HQ-OAR-2009-0566,Extension of Global Laboratory and Analytical Use Exemption (2005) - Final Rule,Supporting & Related Material,Federal Register Document,2009-12-11T05:00:00Z,2009,12,,,2011-06-11T16:05:50Z,,0,0,0900006480a567f6
EPA-HQ-OAR-2009-0566-0022,EPA,EPA-HQ-OAR-2009-0566,"Removal of Essential Use Designation (2008, 7 epinephrine) - Final Rule",Supporting & Related Material,Federal Register Document,2009-12-11T05:00:00Z,2009,12,,,2011-06-11T16:05:50Z,,0,0,0900006480a56869
EPA-HQ-OAR-2009-0566-0017,EPA,EPA-HQ-OAR-2009-0566,Extension of De Minimus Exemption for Essential Laboratory and Analytical Use (2002) - Final Rule,Supporting & Related Material,Federal Register Document,2009-12-11T05:00:00Z,2009,12,,,2011-06-11T16:05:51Z,,0,0,0900006480a567f5
EPA-HQ-OAR-2009-0566-0002,EPA,EPA-HQ-OAR-2009-0566,"January 7, 2009 US EPA Letter to Metered Dose Inhaler (MDI) Manufacturers",Supporting & Related Material,"Letter, Memorandum, Email",2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:24:25Z,,0,0,0900006480a565f1
EPA-HQ-OAR-2009-0566-0007,EPA,EPA-HQ-OAR-2009-0566,Decision IV/25,Supporting & Related Material,"Guidance, Interpretation, Policy, Procedure",2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:24:41Z,,0,0,0900006480a5664e
EPA-HQ-OAR-2009-0566-0020,EPA,EPA-HQ-OAR-2009-0566,"Removal of Essential Use Designation (2005, albuterol) - Final Rule",Supporting & Related Material,Federal Register Document,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:25:22Z,,0,0,0900006480a56867
EPA-HQ-OAR-2009-0566-0029,EPA,EPA-HQ-OAR-2009-0566,Wyeth's confidential business information (CBI) response to EPA's January 7 letter,Supporting & Related Material,Data,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:25:50Z,,0,0,0900006480a568cf
EPA-HQ-OAR-2009-0566-0003,EPA,EPA-HQ-OAR-2009-0566,"April 1, 2009 US EPA Letter to Food and Drug Administration (FDA) Acting Commisioner Joshua M. Sharfstein, M. D.",Supporting & Related Material,"Letter, Memorandum, Email",2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:24:28Z,,0,0,0900006480a565fc
EPA-HQ-OAR-2009-0566-0011,EPA,EPA-HQ-OAR-2009-0566,Decision XIX/13,Supporting & Related Material,Other,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:24:53Z,,0,0,0900006480a566c1
EPA-HQ-OAR-2009-0566-0012,EPA,EPA-HQ-OAR-2009-0566,Decision XIX/18,Supporting & Related Material,Study,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:24:56Z,,0,0,0900006480a566c2
EPA-HQ-OAR-2009-0566-0019,EPA,EPA-HQ-OAR-2009-0566,Extension of Global Laboratory and Analytical Use Exemption (2007) - Final Rule,Supporting & Related Material,Federal Register Document,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:25:19Z,,0,0,0900006480a56866
EPA-HQ-OAR-2009-0566-0005,EPA,EPA-HQ-OAR-2009-0566,"2008 US Essential Use Accouting Framework (March 12, 2009)",Supporting & Related Material,"Letter, Memorandum, Email",2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:24:34Z,,0,0,0900006480a56614
EPA-HQ-OAR-2009-0566-0023,EPA,EPA-HQ-OAR-2009-0566,3M's confidential business information (CBI) response to EPA's January 7 letter,Supporting & Related Material,Data,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:25:31Z,,0,0,0900006480a56870
EPA-HQ-OAR-2009-0566-0024,EPA,EPA-HQ-OAR-2009-0566,Armstrong Pharmaceutical Inc's confidential business information (CBI) response to EPA's January 7 letter,Supporting & Related Material,Data,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:25:34Z,,0,0,0900006480a568ca
EPA-HQ-OAR-2009-0566-0016,EPA,EPA-HQ-OAR-2009-0566,Allocation of Essential Use Allowances for 2009 - Final Rule,Supporting & Related Material,Federal Register Document,2009-12-11T05:00:00Z,2009,12,,,2011-06-11T16:05:49Z,,0,0,0900006480a5677a
EPA-HQ-OAR-2009-0566-0026,EPA,EPA-HQ-OAR-2009-0566,Graceway Pharmaceutical's confidential business information (CBI) response to EPA's January 7 letter,Supporting & Related Material,Data,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:25:40Z,,0,0,0900006480a568cc
EPA-HQ-OAR-2009-0566-0027,EPA,EPA-HQ-OAR-2009-0566,Inyx USA Ltd's confidential business information (CBI) response to EPA's January 7 letter,Supporting & Related Material,Data,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:25:43Z,,0,0,0900006480a568cd
EPA-HQ-OAR-2009-0566-0014,EPA,EPA-HQ-OAR-2009-0566,Decision XI/15,Supporting & Related Material,Other,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:25:03Z,,0,0,0900006480a5674f
EPA-HQ-OAR-2009-0566-0021,EPA,EPA-HQ-OAR-2009-0566,"Removal of Essential Use Designation (2007, 7 moieties) - Proposed Rule",Supporting & Related Material,Federal Register Document,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:25:25Z,,0,0,0900006480a56868
EPA-HQ-OAR-2009-0566-0028,EPA,EPA-HQ-OAR-2009-0566,Schering-Plough's confidential business information (CBI) response to EPA's January 7 letter,Supporting & Related Material,Data,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:25:46Z,,0,0,0900006480a568ce
EPA-HQ-OAR-2009-0566-0009,EPA,EPA-HQ-OAR-2009-0566,Decision XV/8,Supporting & Related Material,Other,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:24:47Z,,0,0,0900006480a566be
EPA-HQ-OAR-2009-0566-0025,EPA,EPA-HQ-OAR-2009-0566,Boehringer Ingelheim Pharmaceutical Inc's confidential business information (CBI) response to EPA's January 7 letter,Supporting & Related Material,Data,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:25:37Z,,0,0,0900006480a568cb
EPA-HQ-OAR-2009-0566-0004,EPA,EPA-HQ-OAR-2009-0566,"July 10, 2009 US Food and Drug Adminstration (FDA) Detemination Letter",Supporting & Related Material,"Letter, Memorandum, Email",2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:24:31Z,,0,0,0900006480a56613
EPA-HQ-OAR-2009-0566-0013,EPA,EPA-HQ-OAR-2009-0566,Decision X/19,Supporting & Related Material,Other,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:25:00Z,,0,0,0900006480a5674e
EPA-HQ-OAR-2009-0566-0010,EPA,EPA-HQ-OAR-2009-0566,Decision XVII/5,Supporting & Related Material,Other,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:24:50Z,,0,0,0900006480a566c0
EPA-HQ-OAR-2009-0566-0015,EPA,EPA-HQ-OAR-2009-0566,Allocation of Essential Use Allowances for 2009 - Proposed Rule,Supporting & Related Material,Federal Register Document,2009-12-11T05:00:00Z,2009,12,,,2009-12-11T16:25:06Z,,0,0,0900006480a56751
EPA-HQ-OAR-2009-0566-0001,EPA,EPA-HQ-OAR-2009-0566,Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2010,Proposed Rule,Federal Register Document,2009-12-11T05:00:00Z,2009,12,2009-12-11T05:00:00Z,2010-01-12T04:59:59Z,2011-06-11T16:05:51Z,E9-29556,0,0,0900006480a6928e